Russia reported 9,434 new cases of coronavirus and 139 deaths in the last 24 hours, bringing the total number of infected to 335,882 and the death toll to 3,388, according to the latest official data.
For the eighth consecutive day, the figure is less than the 10,000 daily cases that the Asian country had been reporting, where people recovered every day began to overcome new infections for the first time this week.
Yesterday, Russian President Vladimir Putin gave a message to the population in which he assured that the outbreak stabilized and that the “dynamic is positive.”
“According to the objective information we receive and the experts’ assessments, the situation at a general level in the country stabilizes. Both in Moscow and in many other Russian regions, the number of new daily infections is gradually decreasing,” said Putin.
In Moscow, the epicenter of the pandemic in the country, 3,190 new cases of coronavirus were detected in the last 24 hours, bringing the total number of infected in the capital to 161,397.
In addition, 67 people died in Moscow from Covid-19 in the last 24 hours, so that so far there are 1,934 lives that the disease has claimed in the Russian capital.
A large-scale program to detect antibodies in Muscovites began in Moscow on May 15.
The authorities plan to carry out up to 6 million tests within the framework of the seroprevalence study, which would be half the population of the capital.
So far, more than 50,000 have been made, the head of the capital’s health department Alexei Khripun reported today, quoted by the EFE news agency.
Antibodies have been detected in 12.5% of those tested, he said.
“We see that the proportion of Muscovites that develop immunity to the coronavirus is comparable to that of some other cities in the world,” he explained.
At the national level, the Russian health chief, Anna Popova, reported that massive immunity tests are planned to start from the end of June and that 0.5% of the 146 million inhabitants of Russia are scheduled to be tested.
On the other hand, the director of the Nikolai Gamaleya Institute of Russia, Alexandr Guintsburg, reported that the center plans to start production of its Covid-19 vaccine in late summer.
At a press conference, the expert noted that preliminary trials of the vaccine in animals showed good results and that he hopes to be able to apply for authorization to proceed to clinical trials in humans in the first half of June.